PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAB7. A total of 2 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,592,000 | -62.7% | 3,423,000 | -62.0% | 0.04% | -59.6% |
| Q2 2017 | $6,953,000 | 0.0% | 9,000,000 | 0.0% | 0.10% | +3.0% |
| Q1 2017 | $6,953,000 | -46.4% | 9,000,000 | -55.2% | 0.10% | -50.7% |
| Q3 2016 | $12,965,000 | -2.6% | 20,072,000 | 0.0% | 0.20% | -5.5% |
| Q2 2016 | $13,310,000 | -2.1% | 20,072,000 | 0.0% | 0.22% | -4.0% |
| Q1 2016 | $13,599,000 | -50.8% | 20,072,000 | -50.0% | 0.23% | +6.1% |
| Q4 2015 | $27,624,000 | +105.6% | 40,144,000 | +112.7% | 0.21% | +2.9% |
| Q3 2015 | $13,435,000 | -0.4% | 18,872,000 | +5.6% | 0.21% | +21.8% |
| Q2 2015 | $13,493,000 | +7.8% | 17,872,000 | +6.6% | 0.17% | -1.7% |
| Q1 2015 | $12,516,000 | -1.2% | 16,772,000 | 0.0% | 0.17% | +6.8% |
| Q4 2014 | $12,674,000 | – | 16,772,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 4,000,000 | $2,698,000 | 2.68% |
| Opaleye Management Inc. | 3,640,000 | $4,295,000 | 2.11% |
| Mohican Financial Management, LLC | 2,600,000 | $1,851,000 | 1.41% |
| Camber Capital Management LP | 9,000,000 | $6,182,000 | 0.53% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 18,872,000 | $13,435,000 | 0.21% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 10,000,000 | $7,430,000,000 | 0.15% |
| ANGELO GORDON & CO., L.P. | 2,500,000 | $1,780,000 | 0.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,977,000 | $4,944,000 | 0.12% |
| Baker Brothers Advisors | 3,423,000 | $2,450,000 | 0.02% |
| FEDERATED HERMES, INC. | 5,330,000 | $3,631,000 | 0.01% |